Data from clinical cases and animal models provide strong evidence indicating that anti‐inflammation could be main therapeutic target in the uveitis treatment 5 and vascular endothelial growth factor (VEGF) inhibition could be considered as an option for treating uveitis 8. The gene discussed is VEGFA; the disease is uveitis.